Public campaign aimed at increasing ED awareness

Article

The Sexual Medicine Society of North America has announced a public education program commemorating a decade of treatment for erectile dysfunction: The first tablet to treat ED was introduced 10 years ago.

The Sexual Medicine Society of North America has announced a public education program commemorating a decade of treatment for erectile dysfunction: The first tablet to treat ED was introduced 10 years ago.

The goal of the educational campaign is to increase awareness and understanding of ED and its relationship to cardiovascular health and to provide evidence-based information on other men’s health topics. The first phase of the program will consist of a series of town hall meetings across North America, to which men and their spouses will be invited to directly question experts on all aspects of men’s sexual health.

It is hoped that this first phase of the program will stimulate a national conversation on men’s health. The first town hall meeting will be held in Toronto in October 2008. This meeting, as well as those that follow, will be edited into a series of web casts that will be available on the society’s web site: www.smsna.org.

Related Videos
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.